The crystal structure of myelin oligodendrocyte glycoprotein, a key autoantigen in multiple sclerosis
about
Identification of the myelin oligodendrocyte glycoprotein as a cellular receptor for rubella virusThe Role of Indoleamine 2, 3-Dioxygenase in Immune Suppression and AutoimmunityCharacterization of a Putative Receptor Binding Surface on Skint-1, a Critical Determinant of Dendritic Epidermal T Cell Selection.The Molecular Basis for Modulation of Human V 9V 2 T Cell Responses by CD277/Butyrophilin-3 (BTN3A)-specific AntibodiesButyrophilin 3A1 binds phosphorylated antigens and stimulates human γδ T cellsMyelin-specific proteins: a structurally diverse group of membrane-interacting molecules.Recombinant Escherichia coli produces tailor-made biopolyester granules for applications in fluorescence activated cell sorting: functional display of the mouse interleukin-2 and myelin oligodendrocyte glycoprotein.Bacterial inclusion bodies contain amyloid-like structureCNS myelin induces regulatory functions of DC-SIGN-expressing, antigen-presenting cells via cognate interaction with MOGA switch in pathogenic mechanism in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in IFN-γ-inducible lysosomal thiol reductase-free mice.Amniotic epithelial cells from the human placenta potently suppress a mouse model of multiple sclerosis.SCER and SCAN: two novel high-prevalence antigens in the Scianna blood group system.Disturbed macro-connectivity in schizophrenia linked to oligodendrocyte dysfunction: from structural findings to molecules.Towards revealing the structure of bacterial inclusion bodies.Amiloride improves locomotor recovery after spinal cord injury.A missense mutation in myelin oligodendrocyte glycoprotein as a cause of familial narcolepsy with cataplexy.Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.Glycoproteins as targets of autoantibodies in CNS inflammation: MOG and more.B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunityThe myelin oligodendrocyte glycoprotein directly binds nerve growth factor to modulate central axon circuitry.Critical role of activation induced cytidine deaminase in experimental autoimmune encephalomyelitis.Ancient evolutionary origin of diversified variable regions demonstrated by crystal structures of an immune-type receptor in amphioxusMyelin-reactive antibodies initiate T cell-mediated CNS autoimmune disease by opsonization of endogenous antigen.Treatment of spontaneous EAE by laquinimod reduces Tfh, B cell aggregates, and disease progression.B cell-derived transforming growth factor-β1 expression limits the induction phase of autoimmune neuroinflammation.MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies.The primate autoimmune encephalomyelitis model; a bridge between mouse and man.The Role of Peripheral CNS-Directed Antibodies in Promoting Inflammatory CNS Demyelination.Experimental Models of Autoimmune Demyelinating Diseases in Nonhuman Primates.Different modes of variation for each BG lineage suggest different functions.Essential role for CCR6 in certain inflammatory diseases demonstrated using specific antagonist and knockin mice.The high resolution crystal structure of the human tumor suppressor maspin reveals a novel conformational switch in the G-helix.Methylprednisolone induces reversible clinical and pathological remission and loss of lymphocyte reactivity to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis.Scavenger Receptor A Mediates the Clearance and Immunological Screening of MDA-Modified Antigen by M2-Type Macrophages.Optic Neuritis: A Model for the Immuno-pathogenesis of Central Nervous System Inflammatory Demyelinating Diseases.Dependency of Experimental Autoimmune Encephalomyelitis Induction on MOG35-55 Properties Modulating Matrix Metalloproteinase-9 and Interleukin-6.Computational comparison of two new fusion proteins for multiple sclerosisMyelin-derived and putative molecular mimic peptides share structural properties in aqueous and membrane-like environmentsFunctional characterization of reappearing B cells after anti-CD20 treatment of CNS autoimmune disease
P2860
Q24635006-F74F394F-A643-41E9-8B79-599FB37B9ADCQ26785900-45DDA836-DAC4-496A-886E-109A1B162DF4Q27312069-4ABCDCA5-12F2-4E31-9463-7C474F6521EFQ27670973-CE9259CB-2896-4614-B24F-5E8B337A59CCQ27685257-A66ED5BB-446A-486C-B659-6797EA66F3D2Q30432116-48FDF450-81DF-4A5E-B647-D3718E733EB6Q33268242-6A150413-5345-46D5-8E27-CAF4F62EAFA0Q33358275-5FF8C741-856C-4096-97B7-DB1349462C43Q33826854-EB937E88-9E7C-4931-8B55-E43EC1490AEBQ34046278-EC822400-1B47-42D0-A60D-6C1676DCF759Q34259735-C3748402-466D-49E7-929E-9DED4851B5CBQ34478689-5372FC4C-543C-42CC-BA35-369813AE5547Q34531769-6C3B41DA-7E8C-4F83-BD95-42170FB44CCDQ34612503-3A5B710B-386A-4FB6-9C9E-BC554C670B1AQ35106632-78CBCF90-C852-448C-8C93-6F8130A790AAQ35204907-52661D12-C4D9-4584-83BB-06B179AA7920Q35867011-A40481C5-64F0-47AD-8277-2ECCB49442EDQ35949316-B4703092-2220-4694-9FD7-FC30600B4926Q36034499-D4BE8018-BDEA-438B-9CC1-2352272C090AQ36078270-12AD22C5-5948-4B99-A949-025BC3ECF6E8Q36634895-91654DCA-2DED-425E-9C42-43EB20BB3A7CQ36999025-6F7B9DE9-EB7D-48F3-8083-5A21DB1452E8Q37014400-B2A1D568-746E-4659-83AF-573E642BEC71Q37274895-ACB99C12-E3BE-4F92-8C84-1F8C7E43AE38Q37314912-5503B617-89A6-4E3B-99CF-D19701F69344Q37397820-AA8AD844-255B-4523-84C9-435896D18EC6Q38497590-CF819C52-0733-4F40-85AF-F7E9C69E6252Q38714054-00CA2531-F220-4C25-8D06-23F7A4210E73Q39352482-27CA26B9-B058-4F2A-B1B9-358A68234867Q41241216-6ABF2B3D-87DF-4E0F-9911-7C2C397C4863Q41252379-5327F65D-A377-4F54-9DAD-B029E2AE39E5Q42650519-41BFF09E-00EE-4CC6-9118-2CC487AAD36FQ46528181-740C67E8-8FAF-45D9-BA92-2A99F9BF547CQ47152812-C63C8DD4-FC51-4068-BAC5-6716770234C1Q49336386-C94EE6AB-87B5-4641-9D08-53ADDEFCECAEQ53191163-A54E8FF7-2E39-41A3-A824-CDD8B846C14AQ57062331-9D88DCFF-5A08-4DB8-A58C-3917522063AEQ58455202-E93B3142-3027-4C94-84D0-AC0D9F169ACFQ58758199-50DA6270-EBCE-4CAC-87A6-F5B43BA878E3
P2860
The crystal structure of myelin oligodendrocyte glycoprotein, a key autoantigen in multiple sclerosis
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The crystal structure of myeli ...... oantigen in multiple sclerosis
@ast
The crystal structure of myeli ...... oantigen in multiple sclerosis
@en
The crystal structure of myeli ...... oantigen in multiple sclerosis
@nl
type
label
The crystal structure of myeli ...... oantigen in multiple sclerosis
@ast
The crystal structure of myeli ...... oantigen in multiple sclerosis
@en
The crystal structure of myeli ...... oantigen in multiple sclerosis
@nl
prefLabel
The crystal structure of myeli ...... oantigen in multiple sclerosis
@ast
The crystal structure of myeli ...... oantigen in multiple sclerosis
@en
The crystal structure of myeli ...... oantigen in multiple sclerosis
@nl
P2093
P2860
P50
P921
P3181
P356
P1476
The crystal structure of myeli ...... oantigen in multiple sclerosis
@en
P2093
Craig S Clements
Fleur E Tynan
Hugh H Reid
P2860
P304
11059-11064
P3181
P356
10.1073/PNAS.1833158100
P407
P577
2003-09-05T00:00:00Z